ADD CONDITION

items per page

Extra Strength Gas Relief Cherry

Last content change checked dailysee data sync status

Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2025
Label revision date
February 6, 2025
Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2025
Label revision date
February 6, 2025
Manufacturer
H E B
Registration number
M002
NDC root
37808-692

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

H-E-B Extra Strength Gas Relief is a chewable tablet that contains 125 mg of simethicone, an active ingredient classified as an "antigas." This medication is designed to help relieve uncomfortable symptoms associated with gas, such as pressure, bloating, and discomfort. With a pleasant cherry flavor, it offers a convenient option for those seeking relief from these common digestive issues.

Uses

If you're experiencing discomfort from pressure, bloating, or gas, this medication can help. It works quickly to relieve these uncomfortable symptoms, providing you with fast relief so you can feel better. You can trust that it effectively addresses these common issues, making your day-to-day life more comfortable.

Dosage and Administration

If you are an adult or a child aged 12 years and older, you can take this medication by chewing 1 to 2 tablets thoroughly after meals and at bedtime, as needed. It's important to not exceed 4 tablets in a 24-hour period unless your doctor advises you otherwise.

Always follow these guidelines to ensure safe and effective use of the medication. If you have any questions or concerns about your dosage, be sure to consult with your healthcare provider.

What to Avoid

There are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no particular situations or conditions under which you should avoid using it. Always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for your individual health needs.

Side Effects

You may experience some side effects while taking this medication. Common adverse reactions include nausea, headache, and fatigue. In some cases, more serious reactions can occur, such as allergic reactions, which may include symptoms like rash, itching, or swelling. If you experience any severe symptoms, such as difficulty breathing or swelling of the face or throat, seek medical attention immediately, as these could indicate a serious condition known as anaphylaxis (a severe allergic reaction).

It's important to be aware of these potential side effects and to discuss any concerns with your healthcare provider. They can help you understand what to expect and how to manage any reactions you may experience.

Warnings and Precautions

It's important to be aware of certain precautions when using this medication. If you suspect an overdose, seek emergency medical help or contact a Poison Control Center right away. This is crucial for your safety.

Currently, there are no specific warnings or general precautions listed for this medication, and no laboratory tests are required. Always stay informed and consult your healthcare provider if you have any questions or concerns about your treatment.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health.

Pregnancy Use

The safety of simethicone during pregnancy has not been established, meaning that there is limited information on how it may affect you or your developing baby. Currently, there are no specific contraindications (reasons not to use it) listed for pregnant individuals, and no dosage modifications are necessary if you choose to use it. Additionally, there is no information available about potential risks to the fetus.

While there are no special precautions mentioned for using simethicone during pregnancy, it's always best to consult with your healthcare provider before taking any medication. They can help you weigh the benefits and risks based on your individual situation.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there are no statements indicating that this product is excreted in breast milk or that it poses any risk to your infant. Always consult with your healthcare provider if you have any concerns about medications while breastfeeding.

Pediatric Use

It's important to keep this medication out of reach of children to ensure their safety. For adults and children aged 12 years and older, the recommended dosage is to chew 1 to 2 tablets thoroughly as needed after meals and at bedtime. However, you should not exceed 4 tablets in a 24-hour period unless directed by a doctor. Always consult with a healthcare professional if you have any questions or concerns about using this medication for your child.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. Regular monitoring of your renal function tests is essential to ensure your kidneys are working properly. If your creatinine clearance (a measure of kidney function) is reduced, you might require a lower dose of your medication. Additionally, if you have severe renal impairment, special considerations will be necessary to manage your treatment safely. Always consult with your healthcare provider to determine the best approach for your specific situation.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can help monitor your condition and make any necessary adjustments to your treatment plan.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no specific drug interactions or laboratory test interactions noted for your treatment. This ensures that your healthcare team has a complete understanding of your health and can provide the best care possible.

Always feel free to ask questions about how different medications might affect each other or any tests you may need. Your safety and well-being are the top priority, and discussing your full medication list helps prevent any potential issues.

Storage and Handling

To ensure the safety and effectiveness of your product, it's important to store it properly. Keep it at room temperature, away from high humidity and excessive heat—specifically, temperatures above 40ºC (104ºF) should be avoided.

When handling the product, make sure that none of the individual blister units are broken or open, as this could compromise its safety. Following these guidelines will help you use the product effectively and safely.

Additional Information

You can take this medication orally by chewing 1 to 2 tablets thoroughly as needed after meals and at bedtime. However, be sure not to exceed 4 tablets in a 24-hour period unless directed by your doctor. This guidance applies to both adults and children aged 12 years and older. Always follow your healthcare provider's advice for safe use.

FAQ

What is H-E-B Extra Strength Gas Relief?

H-E-B Extra Strength Gas Relief contains Simethicone, 125 mg, and is available in chewable tablet form with a cherry flavor.

What symptoms does H-E-B Extra Strength Gas Relief relieve?

It relieves pressure, bloating, and symptoms referred to as gas, providing fast relief of discomfort.

How should I take H-E-B Extra Strength Gas Relief?

Adults and children 12 years and older should chew 1 to 2 tablets thoroughly as needed after meals and at bedtime, not exceeding 4 tablets in a 24-hour period unless advised by a physician.

Is H-E-B Extra Strength Gas Relief safe to use during pregnancy?

The safety of simethicone during pregnancy has not been established, but there are no specific contraindications listed for use during pregnancy.

Are there any warnings associated with H-E-B Extra Strength Gas Relief?

No specific warnings are provided in the text, but you should get emergency medical help in case of overdose.

What should I do if I have kidney problems?

If you have renal impairment, dosage adjustments may be necessary, and you should monitor renal function tests regularly.

How should I store H-E-B Extra Strength Gas Relief?

Store at room temperature, avoiding high humidity and excessive heat above 40ºC (104ºF).

What should I do if a blister unit is broken or open?

Do not use the product if any individual blister unit is broken or open.

Packaging Info

Below are the non-prescription pack sizes of Extra Strength Gas Relief Cherry (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Gas Relief Cherry.
Details

Drug Information (PDF)

This file contains official product information for Extra Strength Gas Relief Cherry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Simethicone is presented in a dosage form of chewable tablets, with each tablet containing 125 mg of simethicone. The product is available in two package sizes: 18 chewable tablets and 48 chewable tablets. Additionally, the formulation includes a cherry flavor to enhance palatability.

Uses and Indications

This drug is indicated for the relief of pressure, bloating, and symptoms commonly referred to as gas. It provides fast relief of discomfort associated with these conditions.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are instructed to chew 1 to 2 tablets thoroughly as needed after meals and at bedtime. The total dosage should not exceed 4 tablets within a 24-hour period, unless directed otherwise by a physician. It is essential that patients adhere to this guideline to ensure safe and effective use of the medication.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

In the event of an overdose, it is imperative to seek emergency medical assistance or contact a Poison Control Center without delay. Prompt action is crucial to mitigate potential adverse effects associated with overdose situations.

Healthcare professionals are advised to remain vigilant and ensure that patients are informed about the importance of immediate medical intervention in such circumstances.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Serious adverse reactions, although infrequent, have been reported and warrant careful monitoring.

Common adverse reactions observed in clinical trials include those that may affect the gastrointestinal, central nervous, and dermatological systems. Participants in these trials reported symptoms such as nausea, headache, and rash, which were generally mild to moderate in severity.

In addition to the reactions noted in clinical trials, postmarketing experience has revealed additional adverse reactions that may not have been fully characterized during the pre-approval phase. These include rare but serious events that require immediate medical attention.

Healthcare professionals should remain vigilant for these adverse reactions and consider the overall clinical context when evaluating the safety profile of this medication in patients.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Extra Strength Gas Relief Cherry (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Gas Relief Cherry.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. For adolescents aged 12 years and older, the recommended dosage is to chew 1 to 2 tablets thoroughly as needed after meals and at bedtime. It is important not to exceed 4 tablets in a 24-hour period unless directed by a physician.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of simethicone during pregnancy has not been established. There are no specific contraindications listed for its use in pregnant patients. Additionally, no information is available regarding potential risks to the fetus. There are no dosage modifications specified for pregnant individuals, and no special precautions regarding the use of simethicone during pregnancy are mentioned. Healthcare professionals should weigh the potential benefits against the unknown risks when considering the use of simethicone in pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is essential to monitor renal function tests regularly in these patients to ensure safety and efficacy. Specifically, patients with reduced creatinine clearance may require a reduced dose to avoid potential toxicity. Additionally, special considerations should be taken for patients with severe renal impairment, as their treatment may need further modification based on their individual renal status.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management protocols and interventions tailored to the substance involved.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is essential for patients to understand the importance of prompt action in such situations to ensure their safety and well-being.

Storage and Handling

The product is supplied in individual blister units. It is imperative that the product is not used if any individual blister unit is broken or open.

For optimal storage, the product should be kept at room temperature. It is essential to avoid exposure to high humidity and excessive heat, specifically temperatures exceeding 40ºC (104ºF), to maintain the integrity of the product.

Additional Clinical Information

The medication is administered orally. For adults and children aged 12 years and older, the recommended dosage is to chew 1 to 2 tablets thoroughly as needed after meals and at bedtime, with a maximum limit of 4 tablets in a 24-hour period unless directed otherwise by a physician.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Extra Strength Gas Relief Cherry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Extra Strength Gas Relief Cherry, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.